OM vs. SMLR, ELMD, AXGN, EDAP, FONR, VANI, HYPR, ZYXI, CGEN, and HITI
Should you be buying Outset Medical stock or one of its competitors? The main competitors of Outset Medical include Semler Scientific (SMLR), Electromed (ELMD), AxoGen (AXGN), Edap Tms (EDAP), FONAR (FONR), Vivani Medical (VANI), Hyperfine (HYPR), Zynex (ZYXI), Compugen (CGEN), and High Tide (HITI). These companies are all part of the "medical" sector.
Semler Scientific (NASDAQ:SMLR) and Outset Medical (NASDAQ:OM) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, community ranking, valuation, analyst recommendations, media sentiment, risk, profitability, institutional ownership and earnings.
49.4% of Semler Scientific shares are held by institutional investors. 13.0% of Semler Scientific shares are held by company insiders. Comparatively, 3.5% of Outset Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
In the previous week, Outset Medical had 7 more articles in the media than Semler Scientific. MarketBeat recorded 8 mentions for Outset Medical and 1 mentions for Semler Scientific. Outset Medical's average media sentiment score of 0.00 beat Semler Scientific's score of -0.11 indicating that Semler Scientific is being referred to more favorably in the media.
Semler Scientific has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500. Comparatively, Outset Medical has a beta of 1.85, indicating that its stock price is 85% more volatile than the S&P 500.
Semler Scientific has higher earnings, but lower revenue than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks.
Semler Scientific has a net margin of 32.92% compared to Semler Scientific's net margin of -134.93%. Outset Medical's return on equity of 30.36% beat Semler Scientific's return on equity.
Outset Medical has a consensus price target of $5.42, indicating a potential upside of 47.59%. Given Semler Scientific's higher probable upside, analysts clearly believe Outset Medical is more favorable than Semler Scientific.
Outset Medical received 21 more outperform votes than Semler Scientific when rated by MarketBeat users. However, 50.00% of users gave Semler Scientific an outperform vote while only 37.93% of users gave Outset Medical an outperform vote.
Summary
Semler Scientific beats Outset Medical on 13 of the 19 factors compared between the two stocks.
Get Outset Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for OM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Outset Medical Competitors List
Related Companies and Tools
